Hypertriglyceridemia (HTG) during pregnancy may cause serious complications such as acute pancreatitis, gestational diabetes mellitus, and preeclampsia, especially the high mortality rate of maternal acute pancreatitis is of concern.The physiologic increase in triglyceride (TG) levels during pregnancy poses a challenge for the diagnosis of HTG, there are no diagnostic criteria for pregnant women. The management of HTG in pregnancy remains focused on early screening and a scientifically based fat-restricted diet. Omega-3 fatty acid therapy may be considered for those who cannot be controlled after strict dietary restriction and lifestyle changes, and fibrates may be  used in late pregnancy when the benefits outweigh the risks, as appropriate, and plasma exchange may be a safe and effective option for extremely severe patients. TG levels in early pregnancy are associated with maternal postpartum and neonatal prognosis. Further studies on pharmacologic treatments and management for HTG in pregnancy are expected.